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Abstract
Background: Platelet rich plasma (PRP) therapy is widely used in enhancing the recovery of skeletal muscle from injury. However, the impact of
intramuscular delivery of PRP on hematologic and biochemical responses has not been fully elucidated in exercise-induced muscle damage. The
purpose of this investigation the effects of intramuscular delivery of PRP on hematologic and biochemical responses and recovery strategy muscle
damage induced by high intensity muscle exercise (exercise-induced muscle damage, EIMD).
Methods: Moderately active male volunteers participated in this study and were assigned to a control group (control, n = 6) and PRP administration
group (PRP, n = 6). The subjects performed exercise with a load of 80% one repetition maximum (1RM) maximal voluntary contraction of the
elbow flexors until point of exhaustion of the non-dominant arm was reached. The arms were treated with saline or autologous PRP post-24 h
EIMD. Venous blood samples were obtained in the morning to establish a baseline value and 1–4 days post-exercise and were analyzed for serum
ferritin, iron, iron binding capacity (IBC), creatinine kinase (CK), lactate dehydrogenase (LDH), aspartate aminotransferase (AST), and alanine
aminotransferase (ALT).
Results: The baseline levels of plasma iron, ferritin, IBC, CK, LDH, AST, and ALT were similar in both the control and PRP groups. However,
24-h following exercise a significant increase in these parameters was observed in both groups between 1 and 4 days during the recovery period.
Interestingly, PRP administration decreased plasma iron levels compared to the control on the second day post-exercise. Plasma IBC increased in
PRP group from Days 2 to 4 post-exercise compared to the control group whilst PRP administration had no effect on plasma ferritin, CK, AST,
ALT, or LDH.
Conclusion: Acute exhaustive exercise increased muscle damage markers, including plasma iron, IBC, and ferritin levels, indicating muscle
damage induced by exercise. PRP administration improves inflammation by reversing the increase in the iron levels post-exercise without
displaying any myotoxicity and may have a role to play in the recovery of exercise-induced muscle damage.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport.
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1. Introduction
Recently platelet rich plasma (PRP), an autologous deriva-
tive of whole blood containing a supraphysiological concen-
tration of platelets, has gained increasing popularity in both
the scientific literature and the wider media for its potential
application in the treatment of traumatic musculoskeletal and
sports-related injuries, cancer biology, and dermatology. In
addition, it has been reported that PRP administration may
improve recovery from tendon and muscle injuries.1,2 Biologic
healing utilizes the normal mechanisms for tissue repair and
incorporates these at the site of injury. Blood components
such as platelets migrate to the injury site and play an impor-
tant role in tissue repair. Platelets contain various growth
factors and cytokines that initiate and promote healing by
stimulating cell migration, cell proliferation, angiogenesis,
and matrix. Other important bioactive factors released from
platelets include histamine and serotonin, and these platelet
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growth factors enhance DNA synthesis, chemotaxis, and
angiogenesis, increase collagen deposition, and stimulate syn-
thesis of extracellular matrix.3
It is well established that an unaccustomed and strenuous
exercise in the trained and untrained individual can induce
skeletal muscle damage;4 this phenomenon is commonly
known as “exercise-induced muscle damage” (EIMD) and is
determined by the type, intensity, and duration of exercise.5
Moreover, in sports, the eccentric/concentric type of exercise
has been used as a specific training model for muscle strength
improvement during training sessions. However, symptoms of
EIMD include reduced muscular force, increased stiffness,
swelling delayed onset muscle soreness (DOMS), and an
increased blood activity of muscle proteins such as creatine
kinase (CK > 1000 IU/L),4 alanine transaminase (ALT),6
aspartate transaminase (AST),6 lactate dehydrogenase
(LDH) activity,7 and this may have a negative impact on
performance.4 Moreover, EIMD initiates an inflammatory
response associated with secondary muscle damage and
remodeling8 sinceduring the acute phase, both neutrophils
and phagocytic macrophages can release reactive oxygen and
nitrogen species and remove debris by phagocytosis.9 More-
over, recent studies have reported the levels of the iron-
regulatory hormone hepcidin are also increased after
exercise.10–12 Hepcidin is a liver-produced peptide hormone,
up-regulated in response to elevated iron levels and the inflam-
matory cytokine interleukin-6 (IL-6),13,14 and an increase in
hepcidin levels usually occurs as a homeostatic response to
inflammatory stimuli namely the IL-6 or elevated iron levels.13
Peeling et al.11 reported that inflammation, hemolysis, serum
iron, ferritin, and urinary hepcidin were elevated in the high
intensity interval post-running session. As such, the post-
exercise hepcidin response is likely to be homeostatic in
nature, to help control and reduce the elevated levels of serum
iron resulting from the exercise-induced hemolysis.15
Many studies have been published proposing various methods
for treating DOMS, including cryotherapy, anti-inflammatory
medication, stretching, hyperbaric oxygen, homeopathy, ultra-
sound, L-carnitine, rest, light exercise, and electromagnetic
shields.16–21 For example, non-steroidal anti-inflammatory
drugs (NSAIDs) are routinely prescribed to alleviate EIMD-
related symptoms and restore normal physical function of
the muscle.22 However, it has been reported that NSAIDs
act by blocking Cyclooxygenase (COX) and thus they may
have a detrimental effect on muscle regeneration and
super-compensation.20 Moreover, there is moderate to strong
evidence that intramuscularly injected local anaesthetics and
NSAIDs are myotoxic. The administration of PRP has also
been reported to induce myotoxicity, however, the evidence is
conflicting and further studies are required to confirm this as
well as the possible myotoxic effects of corticosteroids.23
Furthermore, clinical and histopathological studies have shown
the potential myotoxicity of intramuscular injections in both
animals and humans,24,25 resulting in pain at the injection site
and histopathological changes of inflammation, necrosis, and
fibrosis. Besides histological changes, the local plasma CK
concentration is the most commonly used valid marker for
skeletal muscle myotoxicity.26–28 There is conflicting evidence
regarding the myotoxicity of intramuscular PRP injections.
Two studies used an animal muscle injury model and reported
increased signs of regeneration, less necrosis, and less granu-
lomatous tissue in the muscles injected with PRP29,30
andautologous conditioned serum (ACS),31 than in control
muscles on histological evaluation for up to 2 weeks. However,
information regarding the myotoxicity of intramuscular PRP
injection or the cross-talk between hematologic and biochemi-
cal response has not been reported in exercise-induced muscle
damage. Therefore, we hypothesized that intramuscular PRP
injection might improve inflammation and beneficial effect on
DOMS and muscle damage induced by exercise without
mytoxicity effects. The objective of the present study was to
investigate whether the myotoxicity effects of the intramuscu-
lar PRP injection can provide an effective recovery strategy for
attenuating DOMS and muscle damage induced by high-
intensity muscle exercise in humans.
2. Methods
2.1. Study design
Twelve moderately active male volunteers participated in
this randomized double-blind placebo-controlled trial to verify
the effects of the intramuscular PRP injection on hematologic,
biochemical response, and mytoxicity on muscle recovery
after an eccentric/concentric exercise. Subjects were randomly
placed into two groups: PRP (n = 6) and control (n = 6), and
they had not been involved in any regular weight-training
program and had no history of injury to the arm, shoulder,
and elbow region. The nature and the risks of the experimen-
tal procedures were explained to the subjects, and signed
informed consent to participate in the study was obtained.
Before the test session, participants were examined and
checked by the use of routine blood analysis by a medically
qualified practioner. Ethical approval was obtained from
The Balikesir University Medical Faculty Ethics Committee
(2013/14) and each participant gave written informed consent
prior to the study.
2.2. Muscle damage exercise protocol
For the exercise-induced muscle damage test, subjects were
seated on a bench with their arm positioned in front of their
body and resting on a padded support, such that their shoulder
was secured at a flexion angle of 0.79 rad (45°) and their
forearm was maintained in the supinated position throughout
the exercise. Subjects were repeatedly weight-loaded upon
dumbbell lowering to achieve an 80% of maximum voluntary
contraction (MVC), 2-min rest between the sets of elbow
extension from the flexed position at 90° to fully extended
position slowly over 5 s, until exhaustion was experienced.
The subjects were also given verbal encouragement by the
investigator to maintain constant speed throughout the proce-
dure. They were instructed to continue their normal activities
and to abstain from any strenuous exercise at least 2 weeks
before the experiment. Moreover, they were asked to continue
their usual food intake, not to change the amount or frequency
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of dietary meat and not to use any dietary supplements, anti-
inflammatory drugs, or anything else that could affect muscle
soreness and damage until the end of the study.
2.3. Platelet-rich plasma and placebo
Each participant was assigned to either receive placebo
(saline) injection or PRP injection in non-dominant arms with
post-24 h DOMS exercise based on computerized randomiza-
tion. PRP preparation was obtained from 8 mL of peripheral
blood which was drawn from the dominant arm and the samples
were centrifuged for 9 min at 3500 revolutions per minute
(H-19F, RegenCentrigel, Regen ACR-C; Regen Lab, Switzer-
land) according to manufacturers recommendation. Subse-
quently, 4 mL of PRP was injected using a 20-gauge needle into
the pain full region of the non-dominant arm under sterile
aseptic conditions. This kit produces 4 mL of PRP from 8 mL
citrated blood. Therefore final platelet concentration is approxi-
mately ≤2 fold over whole blood platelet concentration. Platelet
recovery is reported to be >95% and a leukocyte recovery of
58%.
Venous blood samples were collected pre-, and 4 days post-
exercise, and analyzed for complete blood counts (WBC, RBC,
Hb), serum ferritin, iron (Fe), iron binding capacity (IBC),
CKLDH, AST, and ALT as markers of muscle damage and
inflammation.
2.4. Hematological analysis
For analyses of serum Fe, IBC, and ferritin, blood samples
were collected without any additive and after centrifugation
sera were stored at –20 °C until analyzed. Iron and IBC were
measured spectrophotometricallyin an Advia 1800 analyzer
(Siemens Healthcare, Erlangen, Germany) and ferritin was
measured by immunoturbidimetric assay in an OlympusAU400
analyzer (Beckman Coulter, Brea, CA, USA).
2.5. Biochemical analysis
Following centrifugation at 825 g for 10 min, serum was
analyzed for ALT, AST, CK, and LDH activities using commer-
cially available kits in a chemistry autoanalyser (Cobas Integra
800; Roche Diagnostic GmbH; Mannheim, Germany).
2.6. Statistical analysis
All calculations were performed using SPSS software (SPSS
Inc., Chicago, IL, USA). The values of serum Fe, IBC, ferritin,
ALT, AST, LDH, and CK were presented as raw values as the
area under the curve (AUC) during the experimental period.
The AUC was calculated as the sum of four or five trapezoid
areas separated by each supplement time point. Two-way mixed
model analyses of variance (2 groups × 5 times) with repeated
measures were used. Differences in continuous variables
between groups were assessed using independent t test and
between multiple points within the same group were analyzed
using Student’s paired t test. Data were expressed as
means ± SE and the level of significance was set at p < 0.05.
3. Results
There was no difference in body weight, height, age, and
exercise performance had no significant differences between
PRP and control (Table 1, p > 0.05). The baseline values for
plasma Fe, IBC, ferritin, AST, ALT, LDH, and CK values were
similar between the control and the PRP administered group
(p > 0.05). However, at 24-h following exercise, the plasma Fe,
IBC, AST, ALT, LDH, and CK values significantly increased in
the control and the PRP administered group on Days 1–4 post-
exercise muscle damage (p < 0.01, Fig. 1). Acute exhaustive
muscle exercise also increased the plasma ferritin levels in
control and PRP group (p < 0.01 and p < 0.05, respectively,
Fig. 1C). Interestingly, PRP administration decreased plasma
iron levels (p = 0.002) compared to the control group but this
was only observed on the Days 2 and 3 post-exercise-induced
muscle damage (Fig. 1A). Moreover, plasma IBC levels were
increased in PRP group from Days 1 to 4 post-exercise com-
pared to control group (p < 0.05, Fig. 1B). In contrast, PRP
administration had no effect on plasma ferritin, AST, ALT,
LDH, and CK levels (Fig. 1C–G).
4. Discussion
In this paper we report the effect of single dose of intramus-
cular PRP on Fe levels in exercise-induced muscle damage.
This was a pilot study in which six subjects participated in the
control group and test group, respectively. Acute exhaustive
exercise increased muscle damage markers, including plasma
Fe, IBC, and ferritin levels were increased confirming exercise-
induced muscle damage. PRP administration resulted in improved
muscle recovery from injury without displaying any myotoxicity.
Many methods have been utilised for the treatment of DOMS,
including cryotherapy, anti-inflammatory medication, stretch-
ing, hyperbaric oxygen, homeopathy, ultrasound, L-carnitine,
rest, light exercise, and electromagnetic shields.16–19 Inflamma-
tory conditions have been essentially treated by the use of
non-steroidal anti-inflammatory drugs (NSAIDs) although they
are ineffective in reducing muscle pain and do not increase
muscle performance during DOMS.20–22,32–34 As an alternative
to conventional treatments, platelet-rich therapy has been applied
due to its potential in accelerating muscle healing and reduc-
ing a player’s injury time. As far as we are aware, this study is
the first to examine the effect of intramuscular PRP adminis-
tration on DOMS and muscle damage markers also post-exercise-
induced muscle damage during the recovery period in healthy
human volunteers. Importantly, our results show that the acute
Table 1
The characteristics of the subjects (mean ± SE).
Characteristic PRP (n = 6) Control (n = 6)
Age (year) 23 ± 3 22 ± 2
Height (cm) 183.6 ± 3.2 177.6 ± 8.7
Weight (kg) 94.0 ± 6.9 86.0 ± 7.8
Number of exercise set 13 ± 3 12 ± 2
Repetitions of each set 47 ± 6 44 ± 3
Abbreviation: PRP = administration intramuscular platelet rich plasma.
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exhaustive muscle exercise increased the plasma Fe, IBC, and
ferritin level in both groups. Our findings on plasma Fe, IBC,
and ferritin response to acute exhaustive exercise are in agree-
ment with previous reports10–13 which also reported an increase
in serum Fe, IBC, and ferritin levels linked to the intensity of
the exercise. It seems the increase in serum ferritin levels also
led to an increase in plasma iron and hepcidin levels. A
majority of publications have reported an elevated hepcidin
levels 24 h post-exercise, preceded by acute increase in serum
Fe and inflammation parameters.10–13,35 However, we did not
measure the post-exercise hepcidin levels in this study. The
present study indicates that post-exercise serum Fe, IBC, and
ferritin levels are induced as a result of inflammatory response
due to exhaustive muscle exercise. Speculatively, acute exhaus-
tive exercise increased the free Fe that enters the plasma
and has a reduction-oxidation (redox) potential, which may
promote free radical formation as a result of Fenton and
Harber–Weiss reactions and can result in oxidative damage to
tissues.36 Interestingly, in this study it was observed that PRP
administration reversed the observed increase in plasma Fe
level due to muscle damage 2–3 days post-exercise. Further-
more, plasma IBC levels were up-regulated in PRP group from
Days 1 to 4 post-exercise. On the other hand, PRP administra-
tion depressed the plasma ferritin levels during the recovery
phase compared to control values, but did not reach statistical
significance. These results are novel and to the best of our
knowledge, no data exists concerning the acute effect of
intramuscular PRP administration on plasma Fe, IBC, and
ferritin levels parameters during recovery period in an acute
exercise-induced muscle damage model. In general, related
studies have reported that PRP treatment has anti-inflammatory
properties through its effects on the canonical nuclear factor
κB signalling pathway in multiple cell types including
synoviocytes, macrophages, and chondrocytes.37 In addition,
PRP treatment has suppressed tendon cell inflammation in vitro
and in vivo, marked by the upregulation of COX-1, COX-2,
and mPGES-1 expression with highly PGE2 production.38
Additionally, the present study demonstrated that intramuscu-
lar PRP injection plays a key role as an anti-inflammatory by
suppressing effect of increased free iron in plasma during the
muscle damage recovery. Evidently, we have previously shown
that elbow flexors muscle strength peak torque values were
improved after PRP administration when compared to the
control arm, and this occurred on the same day (Day 2) when
the serum Fe level declined post-exercise-induced muscle
damage (Unpublished data).
Serum CK concentration is the most sensitive indicator of
muscle damage and it begins to rise approximately 2–12 h
after the exhaustive exercise. Exhaustive physical exercise
increases serum enzyme activities such as CK, AST, LDH, and
ALT, hence these are considered as markers for the muscular
damage derived from intense exercise.39 The increased activi-
ties of CK and LDH in serum after exhausted exercise
could act as signals, attracting neutrophils to the damaged
Fig. 1. AUC of plasma (A) iron, (B) IBC, (C) ferritin, (D) AST, (E) ALT, (F) LDH, and (G) CK levels were calculated at baseline and on days 1, 2, 3, and 4
post-exercise induced muscle damage (mean ± SE). ap < 0.05, bp < 0.01, compared with baseline analyzed by repeated measures by ANOVA. *p < 0.05, significant
differences between control and PRP, analyzed by independent-samples t test. AUC = area under the curve; IBC = iron binding capacity; AST = aspartate
aminotransferase; ALT = alanine aminotransferase; LDH = lactate dehydrogenase; CK = creatinine kinase; PRP = platelet rich plasma.
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muscle and initiating the inflammatory response. The mainte-
nance of high CK activities after recovery could be and
indicator of muscle repair.40–42 Our result demonstrate that
CK, AST, ALT, and LDH levels increased post-exercise during
the DOMS period in both groups, indicating muscle damage.
On the other hand, CK concentration is the most commonly
used valid marker for skeletal muscle myotoxicity in the
intramuscular injections.26–28 Although intramuscular PRP in-
jections are commonly used, there is only limited evidence
base for myotoxicity in animals models29–31 and these
studies reported increased signs of regeneration of the muscle
whilst necrosis and granulomatous tissue were decreased in
the muscle injected with PRP when compared to the control,
however, no response to CK levels was reported in these
studies.29–31 Limited human studies have been shown that
intramuscular injection of lidocaine43 and bupivacaine (20 mL)26
lead to an increase in CK levels. Our findings showed that the
plasma level of CK was increased in response to exhaustive
exercise, however, PRP administration did not alter CK levels
in the PRP group compared to control. Hence, intramuscular
PRP injection did not show mytoxicity in exercise-induced
model.
5. Conclusion
Our results indicate that acute exhaustive exercise
increases muscle damage markers, including plasma Fe,
IBC, and ferritin levels. PRP administration improved the
inflammatory resoponse by reversing the observed increase in
Fe levels and may have a role to play in the recovery of
exercise-induced muscle damage. Evidently, intramuscular PRP
injection had no effect on CK levels, indicating that it is not
myotoxic.
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